Weiyi Cheng
Hangzhou, 310051, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Charge Au@Pt NPs combined with 3D STS-Net for adaptive and sensitized radiotherapy of hepatocellular carcinoma: Synergistic enhancement of therapeutic gain across physical and biological dimensions.
Journal: Bioactive materials
Published: January 06, 2026
Pro-ATO/Allicin Liposomes for Dual-Pathway Targeting of p53-Mutant Tumors.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 30, 2025
Self-activated prodrug nanocomposites reprogramming lactic acid metabolism to initiate acidosis-endoplasmic reticulum stress cascade and potentiate immunogenic cell death for enhanced liver cancer therapy.
Journal: Journal of nanobiotechnology
Published: September 08, 2025
Arsenene-Vanadene nanodots co-activate Apoptosis/Ferroptosis for enhanced chemo-immunotherapy.
Journal: Acta biomaterialia
Published: November 06, 2024
Bimetallic MnZnSX Nanotheranostics for Self-Activatable Chemo-Immunotherapy of Hepatocellular Carcinoma via H₂S-Triggered Arsenic Prodrug Activation and Binary cGAS-STING Pathway Modulation.
Journal: Advanced healthcare materials
Published: October 29, 2024
Charged Gold Nanoparticles for Target Identification-Alignment and Automatic Segmentation of CT Image-Guided Adaptive Radiotherapy in Small Hepatocellular Carcinoma.
Journal: Nano letters
Published: July 24, 2024
Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 12, 2023
Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment.
Journal: Pharmaceutics
Published: September 21, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026